Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin.

导出 LinkOut

翻译打印收藏纠错

作者： Jonah A,Moore ^[1] ; Michaela,Meakin ^[1] ; Mikaela H,Earl ^[1] ; Tiffany M,Kummer ^[1] ; Jeremy P,McAleer ^[1] ; Timothy E,Long ^[2]

作者单位： Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA. ^[1] Department of Pharmaceutical Science and Research, School of Pharmacy, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA; Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, One John Marshall Drive, Huntington, WV 25755, USA. Electronic address: longt@marshall.edu. ^[2]

关键词 Antibiotics Caspofungin Flow cytometry MRSA Tolcapone Vancomycin

主题词药物协同作用(Drug Synergism);人类(Humans);耐甲氧西林金黄色葡萄球菌(Methicillin-Resistant Staphylococcus aureus);金黄色葡萄球菌(Staphylococcus aureus);万古霉素(Vancomycin)

DOI 10.1016/j.jgar.2020.03.014

PMID 32247076

发布时间 2021-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Journal of global antimicrobial resistance

2020年22卷

283-289页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin.

Journal of global antimicrobial resistance

相似文献

Journal of global antimicrobial resistance

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effects of caspofungin, tolcapone and other FDA-approved medications on MRSA susceptibility to vancomycin.

Journal of global antimicrobial resistance

相似文献

Journal of global antimicrobial resistance

相关期刊

检索历史清除